Berns EM - Search Results

1

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.

Kriege M, Hollestelle A, Jager A, Huijts PE, Berns EM, Sieuwerts AM, Meijer-van Gelder ME, Collée JM, Devilee P, Hooning MJ, Martens JW, Seynaeve C. Kriege M, et al. Among authors: berns em. Br J Cancer. 2014 Aug 26;111(5):1004-13. doi: 10.1038/bjc.2014.306. Epub 2014 Jun 10. Br J Cancer. 2014. PMID: 24918820 Free PMC article.

2

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.

Foekens JA, Sieuwerts AM, Stuurman-Smeets EM, Dorssers LC, Berns EM, Klijn JG. Foekens JA, et al. Among authors: berns em. Int J Cancer. 1992 May 28;51(3):439-44. doi: 10.1002/ijc.2910510317. Int J Cancer. 1992. PMID: 1592534 Free article.

3

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA. Berns EM, et al. Cancer Res. 1992 Mar 1;52(5):1107-13. Cancer Res. 1992. PMID: 1737370

4

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.

Berns EM, Klijn JG, Smid M, van Staveren IL, Gruis NA, Foekens JA. Berns EM, et al. Br J Cancer. 1995 Oct;72(4):964-7. doi: 10.1038/bjc.1995.442. Br J Cancer. 1995. PMID: 7547249 Free PMC article.

5

Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.

Abeln EC, Kuipers-Dijkshoorn NJ, Berns EM, Henzen-Logmans SC, Fleuren GJ, Cornelisse CJ. Abeln EC, et al. Among authors: berns em. Br J Cancer. 1995 Nov;72(5):1330-6. doi: 10.1038/bjc.1995.510. Br J Cancer. 1995. PMID: 7577492 Free PMC article.

6

Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival.

Berns EM, de Klein A, van Putten WL, van Staveren IL, Bootsma A, Klijn JG, Foekens JA. Berns EM, et al. Int J Cancer. 1995 Apr 21;64(2):140-5. doi: 10.1002/ijc.2910640212. Int J Cancer. 1995. PMID: 7615356

7

Prognostic factors and response to therapy in breast cancer.

Klijn JG, Berns EM, Foekens JA. Klijn JG, et al. Among authors: berns em. Cancer Surv. 1993;18:165-98. Cancer Surv. 1993. PMID: 8012996 Review.

8

Cell biological factors associated with the response of breast cancer to systemic treatment.

Klijn JG, Berns EM, Bontenbal M, Foekens J. Klijn JG, et al. Among authors: berns em. Cancer Treat Rev. 1993 Apr;19 Suppl B:45-63. doi: 10.1016/0305-7372(93)90007-e. Cancer Treat Rev. 1993. PMID: 8481934 Review.

9

TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.

Berns EM, Klijn JG, Smid M, van Staveren IL, Look MP, van Putten WL, Foekens JA. Berns EM, et al. Genes Chromosomes Cancer. 1996 Jul;16(3):170-9. doi: 10.1002/(SICI)1098-2264(199607)16:3<170::AID-GCC3>3.0.CO;2-W. Genes Chromosomes Cancer. 1996. PMID: 8814449

10

Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosols.

Berns EM, De Witte HH, Klijn JG, Willman K, Look MP, Meijer-Van Gelder ME, Benraad TJ, Foekens JA. Berns EM, et al. Anticancer Res. 1997 Jul-Aug;17(4B):3003-6. Anticancer Res. 1997. PMID: 9329586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters